From March 1, 2023 to July 27, 2023, the company has repurchased 266,800 shares, representing 0.29% for CAD 0.24 million. With this, the company has completed the repurchase of 296,800 shares, representing 0.33% for CAD 0.26 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 CAD | -1.27% | -3.70% | -6.02% |
1st Jan change | Capi. | |
---|---|---|
-6.02% | 51.4M | |
-.--% | 339M | |
+27.57% | 250M | |
+12.37% | 232M | |
+44.19% | 188M | |
+146.60% | 142M | |
-28.57% | 121M | |
+34.59% | 122M | |
-42.37% | 118M | |
-3.85% | 83.74M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.